Citation: Ka. Freedberg et Ad. Paltiel, COST-EFFECTIVENESS OF PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN AIDS - AN OVERVIEW AND METHODOLOGICAL DISCUSSION, PharmacoEconomics, 14(2), 1998, pp. 165-174
Citation: De. Bonds et Ka. Freedberg, COMBINING UTILITY MEASUREMENTS - EXPLORING DIFFERENT APPROACHES, Medical decision making, 18(4), 1998, pp. 470-470
Authors:
GOLDIE SJ
KUNTZ KM
WEINSTEIN MC
FREEDBERG KA
PALEFSKY JM
Citation: Sj. Goldie et al., COST-EFFECTIVENESS OF SCREENING FOR ANAL SQUAMOUS-CELL CANCER IN HIGH-RISK MEN, Medical decision making, 18(4), 1998, pp. 471-471
Authors:
PALTIEL AD
SCHARFSTEIN JA
SEAGE GR
LOSINA E
GOLDIE SJ
WEINSTEIN MC
CRAVEN DE
FREEDBERG KA
Citation: Ad. Paltiel et al., A MONTE-CARLO SIMULATION OF ADVANCED HIV DISEASE - APPLICATION TO PREVENTION OF CMV INFECTION, Medical decision making, 18(2), 1998, pp. 93-105
Authors:
FREEDBERG KA
SCHARFSTEIN JA
SEAGE GR
LOSINA E
WEINSTEIN MC
CRAVEN DE
PALTIEL AD
Citation: Ka. Freedberg et al., THE COST-EFFECTIVENESS OF PREVENTING AIDS-RELATED OPPORTUNISTIC INFECTIONS, JAMA, the journal of the American Medical Association, 279(2), 1998, pp. 130-136
Citation: Ad. Paltiel et Ka. Freedberg, THE COST-EFFECTIVENESS OF PREVENTING CYTOMEGALOVIRUS DISEASE IN AIDS PATIENTS, Interfaces, 28(3), 1998, pp. 34-51
Authors:
SAMET JH
FREEDBERG KA
STEIN MD
LEWIS R
SAVETSKY J
SULLIVAN L
LEVENSON SM
HINGSON R
Citation: Jh. Samet et al., TRILLION VIRION DELAY - TIME FROM TESTING POSITIVE FOR HIV TO PRESENTATION FOR PRIMARY-CARE, Archives of internal medicine, 158(7), 1998, pp. 734-740
Citation: Ka. Freedberg et al., PROPHYLAXIS FOR DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX (MAC) INFECTION IN PATIENTS WITH AIDS - A COST-EFFECTIVENESS ANALYSIS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(4), 1997, pp. 275-282
Citation: Ja. Scharfstein et al., THE COST-EFFECTIVENESS OF FLUCONAZOLE PROPHYLAXIS AGAINST PRIMARY SYSTEMIC FUNGAL-INFECTIONS IN AIDS PATIENTS, Medical decision making, 17(4), 1997, pp. 373-381
Authors:
FREEDBERG KA
HARDY WD
HOLZMAN RS
TOSTESON ANA
CRAVEN DE
Citation: Ka. Freedberg et al., VALIDATING LITERATURE-BASED MODELS WITH DIRECT CLINICAL-TRIAL RESULTS- THE COST-EFFECTIVENESS OF SECONDARY PROPHYLAXIS FOR PCP IN AIDS PATIENTS, Medical decision making, 16(1), 1996, pp. 29-35
Citation: Ka. Freedberg, CLINICAL AND ECONOMIC-ASPECTS OF PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA, PharmacoEconomics, 7(2), 1995, pp. 95-98
Authors:
LEBOW JM
OCONNELL JJ
ODDLEIFSON S
GALLAGHER KM
SEAGE GR
FREEDBERG KA
Citation: Jm. Lebow et al., AIDS AMONG THE HOMELESS OF BOSTON - A COHORT STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 292-296
Authors:
KAPLAN JE
MASUR H
HOLMES KK
MCNEIL MM
SCHONBERGER LB
NAVIN TR
HANSON DL
GROSS PA
JAFFE HW
LANIER D
SCHRAM N
COOPER E
FREEDBERG KA
MAYER K
BLINKHORN R
ELLNER J
ANGULO F
BERKELMAN R
BREIMAN R
BRYAN R
BUEHLER J
CLADWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KAPLAN JE
KELLER D
MARTONE W
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
TRAPNELL CB
BARR D
TORRES G
STETLER H
GROSS P
ELSADAR W
COTTON D
GREAVES W
BARTLETT J
CHAISSON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
SPERLING R
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/, Clinical infectious diseases, 21, 1995, pp. 1-11
Authors:
KAPLAN JE
MASUR H
HOLMES KK
WILFERT CM
SPERLING R
BAKER SA
TRAPNELL CB
FREEDBERG KA
COTTON D
POWDERLY WG
JAFFE HW
LANIER D
SCHRAM N
COOPER E
MAYER K
BLINKHORN R
ELLNER J
ANGULO J
BERKELMAN R
BREIMAN R
BRYAN R
BEUHLER J
CALDWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KELLER D
MARTONE W
MCNEIL MM
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SCHONBERGER LB
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
BARR D
TORRES G
STETLER H
GROSS P
ELSADR W
GREAVES W
BARTLETT J
CHAISON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/, Clinical infectious diseases, 21, 1995, pp. 12-31
Authors:
KAPLAN JE
MASUR H
HOLMES KK
LANIER D
SCHRAM N
COOPER E
FREEDBERG KA
MAYER K
BLINKHORN R
ELLNER J
ANGULO F
BERKELMAN R
BREIMAN R
BRYAN R
BUEHLER J
CALDWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KELLER D
MARTONE W
MCNEIL MM
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SCHONBERGER LB
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
TRAPNELL CB
BARR D
TORRES G
STETLER H
GROSS P
ELSADR W
COTTON D
GREAVES W
BARTLETT J
CHAISSON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
SPERLING R
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 21, 1995, pp. 32-43
Citation: De. Glotzer et al., MANAGEMENT OF CHILDHOOD LEAD-POISONING - CLINICAL IMPACT AND COST-EFFECTIVENESS, Medical decision making, 15(1), 1995, pp. 13-24
Authors:
BERGQUIST SR
FELSON DT
PRASHKER MJ
FREEDBERG KA
Citation: Sr. Bergquist et al., THE COST-EFFECTIVENESS OF LIVER-BIOPSY IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE, Arthritis and rheumatism, 38(3), 1995, pp. 326-333
Authors:
SAMET JH
LIBMAN H
LABELLE C
STEGER K
LEWIS R
CRAVEN DE
FREEDBERG KA
Citation: Jh. Samet et al., A MODEL CLINIC FOR THE INITIAL EVALUATION AND ESTABLISHMENT OF PRIMARY-CARE FOR PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Archives of internal medicine, 155(15), 1995, pp. 1629-1633
Authors:
ORLANDER JD
SAMET JH
KAZIS L
FREEDBERG KA
LIBMAN H
Citation: Jd. Orlander et al., IMPROVING MEDICAL RESIDENTS ATTITUDES TOWARD HIV-INFECTED PERSONS THROUGH TRAINING IN AN HIV STAGING AND TRIAGE CLINIC, Academic medicine, 69(12), 1994, pp. 1001-1003
Authors:
FREEDBERG KA
MALABANAN A
SAMET JH
LIBMAN H
Citation: Ka. Freedberg et al., INITIAL ASSESSMENT OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - THE YIELD AND COST OF LABORATORY TESTING, Journal of acquired immune deficiency syndromes, 7(11), 1994, pp. 1134-1140
Authors:
GLOTZER DE
BAUCHNER H
FREEDBERG KA
PALFREY S
Citation: De. Glotzer et al., SCREENING FOR CHILDHOOD LEAD-POISONING - A COST-MINIMIZATION ANALYSIS, American journal of public health, 84(1), 1994, pp. 110-112